Conduit vessel stiffness in British south Asians of Indian descent relates to 25-hydroxyvitamin D status

Journal of Hypertension

Volumn 30, Issue 8, 2012, Pages 1588-1596

  Webb, David R ^a   Khunti, Kamlesh ^b   Lacy, Peter ^a   Gray, Laura J ^b   Mostafa, Samiul ^a   Talbot, Duncan ^c   Williams, Bryan ^a   Davies, Melanie J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNILEVER RESEARCH   (United Kingdom)

Author keywords

arterial stiffness; ethnicity; pulse wave velocity; south Asians; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE; INSULIN;

ADULT; ANTHROPOMETRY; ARTERIAL STIFFNESS; ARTERIOSCLEROSIS; ARTICLE; ASIAN; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; ETHNICITY; EUROPE; FEMALE; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REST; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE;

EID: 84863846110     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328354f385     Document Type: Article

References (51)

1. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk factors for early myocardial infarction in south Asians compared with individuals in other countries. JAMA 2007; 297:286-294.
2. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356:279-284.
3. Wild SH, Fischbacher C, Brock A, Griffiths C, Bhopal R. Mortality from all causes and circulatory disease by country of birth in England and Wales 2001-2003. J Publ Health 2007; 29:191-198.
4. Williams ED, Stamatakis E, Chandola T, Hamer M. Physical activity behaviour and coronary heart disease mortality among south Asian people in the UK: an observational longitudinal study. Heart 2011; 97:655-659.
5. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in south Asians. Lancet 1991; 337:382-386.
6. Forouhi NG, Sattar N. CVD risk factors and ethnicity: a homogeneous relationship? Atherosclerosis Suppl 2006; 7:11-19.
7. Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N. Do known risk factors explain the higher coronary heart disease mortality in south Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia 2006; 49:2580-2588.
8. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-1956.
9. Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 2008; 29:361-368.
10. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167:1159-1165.
11. Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitaminD concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvutamin D data from NHANES 2001-2006. Am J Nutrition 2011; 94:225-233.
12. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007; 20:713-719.
13. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk of type 2 diabetes. Diabet Care 2010; 33:1379-1381.
14. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willet WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. J Hypertens 2007; 49:1063-1069.
15. Burgaz A, Orsinni N, Lasson S, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011; 29:636-645.
16. Robinson JG, Manson JE, Larson J. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabet Care 2011; 34:628-634.
17. Pittas AG, Chung M, Trkalinos T, Mitri J, Brendel BA, Patel K, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152:307-314.
18. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in the prevention of cardiovascular events. Ann Intern Med 2010; 152:315-323.
19. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167:1730-1737.
20. Witham M, Nadir NM, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009; 27:1948-1954.
21. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Current Opin Clin Nutr Metab Care 2008; 11:7-12.
22. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. Am Coll Cardiol 2011; 58:186-192.
23. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, et al. Mineral metabolism and arterial functions in endstage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007; 18:613-620.
24. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96:1755-1760.
25. McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 2009; 53: 524-531.
26. Judd SE, Nanes MS, Zielgler TR, Wilson PWF, Tangpricha V. Optimal vitaminD status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination survey. Am J Clin Nutr 2008; 87:136-141.
27. Chaturvedi N, Bulpitt CJ, Leggetter S, Schiff R, Nihoyannopoulos P, Strain WD, et al. Ethnic differences in vascular stiffness and relations to hypertensive target organ damage. J Hypertens 2004; 22:1731-1737.
28. Ferreira AV, Viana MC, Mill JG, Asmar RG, Cunha RS. Racial differences in aortic stiffness in normotensive and hypertensive adults. J Hypertens 1999; 17:631-637.
29. Kalra L, Iveson E, Rambaran C, Sherwood R, Chowienczyk P, Ritter J, et al. An international matched cohort study of the contribution of metabolic impairments to subclinical atherosclerosis in United Kingdom and Jamaican African-Caribbeans. Atherosclerosis 2008; 199:95-101.
30. Strain WD, Chaturvedi N, Dockery F, Shiff R, Shore AC, Bulpitt CJ, et al. Increased arterial stiffness in Europeans and African Caribbeans with type 2 diabetes cannot be accounted for by conventional cardiovascular risk factors. Am J Hypertens 2006; 19:889-896.
31. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Racial (black-white) divergence in the association between adiponectin and arterial stiffness in asymptomatic young adults: the Bogalusa Heart Study. Am J Hypertens 2008; 21:553-557.
32. Pinto ES, Mensah R, Meeran K, Cameron JD, Murugaesu N, Bulpitt CJ, et al. Peripheral arterial compliance differs between races: comparison among Asian, Afro-Caribbeans, and white Caucasians with type 2 diabetes. Diabet Care 2005; 28:496.
33. Gunarathne A, Patel JV, Gammon B, Hughes EA, Lip GY. Impact of mean arterial blood pressure on higher arterial stiffness indices in south Asians compared to white Europeans. J Hypertens 2008; 26:1420-1426.
34. Rezai M-R, Wallace AM, Sattar N, Finn JD, Wu FCW, Cruickshank JW. Ethnic differences in aortic pulse wave velocity occur in the descending aorta and may be related to vitamin D. Hypertension 2011; 58:247-253.
35. Webb DR, Gray LJ, Khunti K, Srinivasan B, Taub N, Campbell S, et al. Screening for diabetes using an oral glucose tolerance test within a westernmultiethnic population identifiesmodifiable cardiovascular risk. The ADDITION-Leicester study. Diabetologia 2011; 54:2237-2246.
36. Webb D, Khunti K, Srinivasan B, Gray L, Taub N, Campbell S, et al. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multifactorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials 2010; 11:16.
37. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-Country reliability and validity. Med Sci Sports Exerc 2003; 35:1381-1395.
38. Bos WJ, Verrij E, Vincent HH, Westerhof BE, Parati G, van Montfrans GA. How to assess mean blood pressure properly at the brachial artery level. J Hypertens 2007; 25:751-755.
39. Van B, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. on behalf of the artery society, the European society of hypertension working group on vascular structure and function. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30:445-448.
40. Millasseau SC, Stewart AD, Patel SJ, Redwood SR, Chowienczyk PJ. Evaluation of carotid-femoral pulse wave velocity: influence of timing algorithm and heart rate. Hypertension 2005; 45:222-226.
41. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288:125-132.
42. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol 2005; 4:4.
43. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002; 95:787-796.
44. Bahar-Shany K, Ravid A, Koren R. Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D. J Cell Physiol 2010; 222:729-737.
45. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011; 57:63-69.
46. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabetic Med 2008; 25:320-325.
47. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94:4023-4030.
48. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, et al. A 16-week randomised clinical trial of 2000IU D3 supplementation in black youth: 25 hydroxyvitaminD, adiposity and arterial stiffness. J Clin Endocrinol Metab 2010; 95:4584-4591.
49. Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ. Arterial stiffness in primary hyperparathyroidism. J Clin Endocrinol Metab 2005; 90:3326-3330.
50. Smulyan H, Marchais SJ, Pannier B, Guerin AP, Safar ME, London GM. Influence of body height on pulsatile arterial haemodynamic data. J Am Coll Cardiol 1998; 31:1103-1109.
51. Lacy PS, O'Brien DG, Stanley AG, Dewar MM, Swales PP, Williams B. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens 2004; 22:1937-1944.